Clin2
NCT06147388Possibly a fitRecruiting

Can cervical precancer heal on its own?

Cervix Uteri SILHPVCIN2CIN3

Part of Cancer, Infections, Women’s health & pregnancy clinical trials.

This study watches to see if early precancerous cells (CIN 2 or 3) on the cervix can go away without treatment, especially in women under 40. It helps doctors understand who might avoid surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 40 years
Study type
Observational

Who can take part

  • You had a cervical biopsy showing CIN 2 or CIN 3 (moderate to severe precancer).
  • You are between 18 and 40 years old.
  • Doctors can see the whole area where the cervix meets the cervical canal (the squamocolumnar junction).
  • You are not pregnant.
  • You do not have HIV or a weakened immune system.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07730645Not yet recruiting
Testing a new low-temperature plasma treatment for cervical precancer

This study tests a new method using low-temperature argon plasma to treat cervical precancer (CIN 2) and compares it with the standard approach of active surveillance. If you have CIN 2 and are between 18 and 40 years old, this trial may offer an alternative to watching and waiting.

Tübingen, Baden-Wurttemberg
NCT06862102Recruiting
Multiple HPV Infections and Cervical Lesion Risk

This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.

Pavia, Pavia
NCT06967740Recruiting
Precancerous Lesions of the Cervix: Better Care Options

This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.

Prague
NCT05282095Recruiting
Study how HPV changes affect outcomes in CIN2

This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.

Fuzhou, Fujian
NCT04057924Recruiting
Watchful waiting for certain abnormal cells in the cervix

This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.

Bordeaux
NCT04783805Recruiting
Watch-and-wait treatment for abnormal cervix cells before future pregnancy

This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.

Barcelona

Hear when a new HPV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.